• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肿瘤大小和患者年龄作为喉癌预后因素的作用。

The role of tumor size and patient's age as prognostic factors in laryngeal cancer.

作者信息

Markou K, Goudakos J, Triaridis S, Konstantinidis J, Vital V, Nikolaou A

机构信息

1 Department of Otorhinolangology, AHEPA University Hospital, Thessaloniki, Greece.

出版信息

Hippokratia. 2011 Jan;15(1):75-80.

PMID:21607041
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3093151/
Abstract

BACKGROUND AND AIM

The loco-regional recurrence of laryngeal carcinoma in patients who underwent total laryngectomy is related to numerous factors. Aim of the present study was to investigate the role of patient's age and tumor size in the recurrence rate of patients. Additional aim of the current study was to investigate the possible associations between the size of the tumor and other characteristics.

PATIENTS AND METHODS

In 1st Department of Otorhinolaryngology of AHEPA University Hospital, from 1992 to 2007, 255 patients with laryngeal carcinoma underwent total laryngectomy. Accurate data regarding the size of the tumor were obtained. Total laryngectomy was the initial treatment in 212 patients, while in the remaining 43 patients was performed as salvage surgery after recurrence.

RESULTS

The median tumor size was 2.74 cm (0.8-5.5 cm). There was no significant difference in the median tumor size between the patients who had recurrence (2.87 cm) and the disease free patients (2.69 cm). The median size of glottic tumors (2.47 cm) was smaller than that of supraglottic (2.95 cm) and of subglottic tumors (3.27 cm) (p<0.05). Among the 255 patients, recurrence of the tumor occurred in 73 (28.7%). Statistical analysis of the data showed that the tumor size was affecting the recurrence rate in a different manner, according the stage of the tumor. The recurrence rate in T3 neoplasms was higher in larger tumors than in smaller (13.2% for tumors<2cm, 62% for tumors>4cm), while T4 carcinomas appeared to have the opposite behavior (66.5% for tumors <2cm, 23% for tumors >4cm). The median tumor size in T4 patients that recurred was smaller than in those with no recurrence (2.8 cm Vs 3.3 cm). This behavior was observed in T4 tumors from all sites. Patients who experienced recurrence and had positive neck lymph nodes at the time of the initial diagnosis appeared to have smaller laryngeal tumors (2.7 cm), compared to with the same group of patients with no recurrence (3.5 cm). Supraglottic location and advanced T stage showed a statistically significant impact on disease free survival, based on Cox regression model.

CONCLUSIONS

Smaller sized tumors in patients with locally advanced laryngeal cancer (T4) or regionally (N+) appear to have more aggressive behavior and higher recurrence rate. Thus, the small tumor size could be regarded as an unfavorable prognostic factor for those laryngeal cancer cases.

摘要

背景与目的

接受全喉切除术的喉癌患者局部区域复发与多种因素相关。本研究的目的是调查患者年龄和肿瘤大小对患者复发率的作用。本研究的另一目的是调查肿瘤大小与其他特征之间可能存在的关联。

患者与方法

在阿赫帕大学医院耳鼻喉科第一科室,1992年至2007年期间,255例喉癌患者接受了全喉切除术。获取了关于肿瘤大小的准确数据。212例患者将全喉切除术作为初始治疗,而其余43例患者在复发后进行挽救性手术。

结果

肿瘤大小中位数为2.74厘米(0.8 - 5.5厘米)。复发患者(2.87厘米)与无疾病患者(2.69厘米)的肿瘤大小中位数无显著差异。声门区肿瘤的大小中位数(2.4,7厘米)小于声门上区(2.95厘米)和声门下区肿瘤(3.27厘米)(p<0.05)。在这255例患者中,73例(28.7%)出现肿瘤复发。对数据的统计分析表明,根据肿瘤分期,肿瘤大小对复发率的影响方式不同。T3期肿瘤中,较大肿瘤的复发率高于较小肿瘤(肿瘤<2厘米者为13.2%,肿瘤>4厘米者为62%),而T4期癌表现出相反的情况(肿瘤<2厘米者为66.5%,肿瘤>4厘米者为23%)。复发的T4期患者的肿瘤大小中位数小于未复发患者(2.8厘米对vs,3.3厘米)。在所有部位的T4期肿瘤中均观察到这种情况。与初始诊断时颈部淋巴结无转移且未复发的同一组患者相比,初始诊断时颈部淋巴结转移且复发的患者喉肿瘤似乎较小(2.7厘米)。基于Cox回归模型分析,声门上区位置和T分期进展对无病生存期有统计学显著影响。

结论

局部晚期喉癌(T4)或区域转移(N+)患者中较小的肿瘤似乎具有更侵袭性的行为和更高的复发率。因此,对于那些喉癌病例,小肿瘤大小可被视为一个不利的预后因素。

相似文献

1
The role of tumor size and patient's age as prognostic factors in laryngeal cancer.肿瘤大小和患者年龄作为喉癌预后因素的作用。
Hippokratia. 2011 Jan;15(1):75-80.
2
Factors influencing tumour relapse after total laryngectomy.全喉切除术后影响肿瘤复发的因素。
B-ENT. 2005;1(1):1-10.
3
Delayed regional metastases, distant metastases, and second primary malignancies in squamous cell carcinomas of the larynx and hypopharynx.喉和下咽鳞状细胞癌的区域转移延迟、远处转移及第二原发性恶性肿瘤
Laryngoscope. 2001 Jun;111(6):1079-87. doi: 10.1097/00005537-200106000-00028.
4
[Primary radiotherapy of laryngeal carcinoma. An analysis of the therapeutic results and of the the relapse behavior in 283 patients].[喉癌的原发性放射治疗。283例患者治疗结果及复发情况分析]
Strahlenther Onkol. 1997 Feb;173(2):83-90. doi: 10.1007/BF03038927.
5
Management of stage IV glottic carcinoma: therapeutic outcomes.IV期声门癌的治疗:治疗结果
Laryngoscope. 2004 Aug;114(8):1438-46. doi: 10.1097/00005537-200408000-00024.
6
Regional metastases in patients with advanced laryngeal cancer. Department of Veterans Affairs Laryngeal Cancer Study Group.晚期喉癌患者的区域转移。退伍军人事务部喉癌研究小组。
Arch Otolaryngol Head Neck Surg. 1996 Jun;122(6):644-8. doi: 10.1001/archotol.1996.01890180052013.
7
[Clinical study of laryngeal cancer].[喉癌的临床研究]
Nihon Jibiinkoka Gakkai Kaiho. 1996 Mar;99(3):385-94. doi: 10.3950/jibiinkoka.99.385.
8
Results of surgical salvage after failure of definitive radiation therapy for early-stage squamous cell carcinoma of the glottic larynx.早期声门型喉鳞状细胞癌根治性放疗失败后的手术挽救结果。
Arch Otolaryngol Head Neck Surg. 2006 Jan;132(1):59-66. doi: 10.1001/archotol.132.1.59.
9
Near-total laryngectomy for laryngeal carcinomas with subglottic extension.针对伴有声门下扩展的喉癌行近全喉切除术。
Arch Otolaryngol Head Neck Surg. 2002 Feb;128(2):177-80. doi: 10.1001/archotol.128.2.177.
10
[Clinical study of subglottic carcinoma].[声门下癌的临床研究]
Nihon Jibiinkoka Gakkai Kaiho. 1995 Feb;98(2):254-9. doi: 10.3950/jibiinkoka.98.254.

引用本文的文献

1
Prognostic significance of nutritional and inflammatory markers in locoregional advanced laryngeal cancer undergoing total laryngectomy.营养和炎症标志物在接受全喉切除术的局部晚期喉癌中的预后意义。
Eur Arch Otorhinolaryngol. 2025 Aug;282(8):4201-4209. doi: 10.1007/s00405-025-09603-6. Epub 2025 Jul 30.
2
Augmentation of Solid Tumor Immunotherapy With IL-12.用白细胞介素-12增强实体瘤免疫疗法
J Gene Med. 2024 Dec;26(12):e70000. doi: 10.1002/jgm.70000.
3
Perineural Invasion Predicts Local Recurrence and Poor Survival in Laryngeal Cancer.神经周围浸润预示喉癌局部复发及预后不良。
J Clin Med. 2023 Jan 5;12(2):449. doi: 10.3390/jcm12020449.
4
Challenges Faced by Clinicians in the Personalized Treatment Planning: A Literature Review and the First Results of the Russian National Cancer Program.临床医生在个性化治疗规划中面临的挑战:文献综述及俄罗斯国家癌症计划的初步结果
Crit Care Res Pract. 2021 Sep 23;2021:6649771. doi: 10.1155/2021/6649771. eCollection 2021.
5
Evaluation of Risk Factors for Laryngeal Squamous Cell Carcinoma: A Single-Center Retrospective Study.喉鳞状细胞癌危险因素评估:一项单中心回顾性研究
Front Oncol. 2021 Feb 25;11:606010. doi: 10.3389/fonc.2021.606010. eCollection 2021.
6
Which risk factors are associated with stomal recurrence after total laryngectomy for laryngeal cancer? A meta-analysis of the last 30 years.喉癌全喉切除术后吻合口复发的相关危险因素有哪些?近 30 年的荟萃分析。
Braz J Otorhinolaryngol. 2020 Jul-Aug;86(4):502-512. doi: 10.1016/j.bjorl.2020.03.002. Epub 2020 Apr 11.
7
Cancer recurrence times from a branching process model.从分支过程模型看癌症复发次数。
PLoS Comput Biol. 2019 Nov 21;15(11):e1007423. doi: 10.1371/journal.pcbi.1007423. eCollection 2019 Nov.
8
LncRNA loc285194 inhibits tumor growth of laryngeal squamous cell carcinoma cells by downregulating hexokinase 2.长链非编码RNA loc285194通过下调己糖激酶2抑制喉鳞状细胞癌细胞的肿瘤生长。
Exp Ther Med. 2019 Oct;18(4):2378-2384. doi: 10.3892/etm.2019.7761. Epub 2019 Jul 9.
9
Retrospective analysis of prognostic factors in 205 patients with laryngeal squamous cell carcinoma who underwent surgical treatment.回顾性分析 205 例行手术治疗的喉鳞状细胞癌患者的预后因素。
PLoS One. 2013 Apr 4;8(4):e60157. doi: 10.1371/journal.pone.0060157. Print 2013.

本文引用的文献

1
Multivariate analysis of prognostic factors in T3 N0 laryngeal carcinoma treated with total laryngectomy.全喉切除术治疗T3 N0期喉癌预后因素的多变量分析。
Otolaryngol Head Neck Surg. 2003 May;128(5):654-62. doi: 10.1016/S0194-59980300228-6.
2
Progression difference between cancers of the larynx and hypopharynx is not due to tumor size and vascularization.喉癌和下咽癌之间的进展差异并非由肿瘤大小和血管形成所致。
Otolaryngol Head Neck Surg. 2001 Jul;125(1):18-22. doi: 10.1067/mhn.2001.116187.
3
Delayed regional metastases, distant metastases, and second primary malignancies in squamous cell carcinomas of the larynx and hypopharynx.喉和下咽鳞状细胞癌的区域转移延迟、远处转移及第二原发性恶性肿瘤
Laryngoscope. 2001 Jun;111(6):1079-87. doi: 10.1097/00005537-200106000-00028.
4
Prognostic factors in squamous cell carcinoma of the larynx.喉鳞状细胞癌的预后因素
ORL J Otorhinolaryngol Relat Spec. 2000 May-Jun;62(3):143-8. doi: 10.1159/000027735.
5
Apoptosis in situ, p53, bcl-2 and AgNOR counts as prognostic factors in laryngeal carcinoma.原位凋亡、p53、bcl-2及核仁组成区嗜银蛋白计数作为喉癌的预后因素
Anticancer Res. 1999 Jan-Feb;19(1B):703-7.
6
Prognostic factors in supraglottic laryngeal carcinoma.声门上型喉癌的预后因素
Otolaryngol Head Neck Surg. 1998 Nov;119(5):548-53. doi: 10.1016/S0194-5998(98)70123-8.
7
The prognostic significance of the biomarkers p21WAF1/CIP1, p53, and bcl-2 in laryngeal squamous cell carcinoma.生物标志物p21WAF1/CIP1、p53和bcl-2在喉鳞状细胞癌中的预后意义。
Cancer. 1998 Jun 1;82(11):2159-65.
8
Blood transfusion and other prognostic variables in the survival of patients with cancer of the head and neck.头颈部癌症患者生存中的输血及其他预后变量
Laryngoscope. 1994 Jan;104(1 Pt 1):95-8. doi: 10.1288/00005537-199401000-00017.
9
Prognostic significance of lymph node reactivity in patients with laryngeal carcinoma.喉癌患者淋巴结反应性的预后意义
Eur Arch Otorhinolaryngol. 1994;251(7):418-22. doi: 10.1007/BF00181968.
10
Discriminant analysis in predicting survival of patients with cancer of the larynx or hypopharynx.判别分析在预测喉癌或下咽癌患者生存率中的应用
Clin Otolaryngol Allied Sci. 1987 Oct;12(5):331-5. doi: 10.1111/j.1365-2273.1987.tb00212.x.